palifermin
Kepivance used for decreasing severe oral mucositis in patients with hematologic malignancies receiving high-dose chemotherapy with stem-cell transplant. Approved for formulary status, use restricted to oncologists .
Reviewed: August 25, 2009
Kepivance used for decreasing severe oral mucositis in patients with hematologic malignancies receiving high-dose chemotherapy with stem-cell transplant. Approved for formulary status, use restricted to oncologists .
Reviewed: August 25, 2009